These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33639995)

  • 21. TOLLIP and MUC5B modulate the effect of ambient NO
    Gorlanova O; Rüttimann C; Soti A; de Hoogh K; Vienneau D; Künstle N; Da Silva Sena CR; Steinberg R; Bovermann X; Schulzke S; Latzin P; Röösli M; Frey U; Müller L
    Chemosphere; 2024 Sep; 363():142837. PubMed ID: 39009092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
    Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
    Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study.
    Manali ED; Kannengiesser C; Borie R; Ba I; Bouros D; Markopoulou A; Antoniou K; Kolilekas L; Papaioannou AI; Tzilas V; Tzouvelekis A; Daniil Z; Fouka E; Papakosta D; Xyfteri A; Karakatsani A; Loukides S; Korbila I; Tomos IP; Konstantinidis AK; Gogali A; Steiropoulos P; Papanikolaou IC; Bazaka C; Haritou A; Vassilakopoulos T; Maniati M; Kagouridis K; Markozannes E; Bouros E; Rampiadou C; Kounti G; Trachalaki A; Dimeas I; Karampitsakos T; Lyberopoulos P; Malamadakis N; Spyropoulou S; Revy P; Lainey E; Dieudé P; Rebah K; Ménard C; Oudin C; Masson C; Plessier A; Legendre M; Nathan N; Coulomb-L'Hermine A; Clement A; Amselem S; Boileau C; Crestani B; Papiris S;
    Respiration; 2022; 101(6):531-543. PubMed ID: 35078193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A
    Verma A; Minnier J; Wan ES; Huffman JE; Gao L; Joseph J; Ho YL; Wu WC; Cho K; Gorman BR; Rajeevan N; Pyarajan S; Garcon H; Meigs JB; Sun YV; Reaven PD; McGeary JE; Suzuki A; Gelernter J; Lynch JA; Petersen JM; Zekavat SM; Natarajan P; Dalal S; Jhala DN; Arjomandi M; Gatsby E; Lynch KE; Bonomo RA; Freiberg M; Pathak GA; Zhou JJ; Donskey CJ; Madduri RK; Wells QS; Huang RDL; Polimanti R; Chang KM; Liao KP; Tsao PS; Wilson PWF; Hung AM; O'Donnell CJ; Gaziano JM; Hauger RL; Iyengar SK; Luoh SW;
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1220-1229. PubMed ID: 35771531
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
    Lewandowska KB; Szturmowicz M; Lechowicz U; Franczuk M; Błasińska K; Falis M; Błaszczyk K; Sobiecka M; Wyrostkiewicz D; Siemion-Szcześniak I; Bartosiewicz M; Radwan-Röhrenschef P; Roży A; Chorostowska-Wynimko J; Tomkowski WZ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human
    Tharavecharak S; Fujimoto H; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Tomaru A; Saiki H; Uemura M; Kogue Y; Ito T; Furuhashi K; Okano T; Takeshita A; Nishihama K; Ono R; Hataji O; Nosaka T; Kobayashi T; Gabazza EC
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese.
    Isshiki T; Koyama K; Homma S; Sakamoto S; Yamasaki A; Shimizu H; Miyoshi S; Nakamura Y; Kishi K
    Sci Rep; 2021 Aug; 11(1):16250. PubMed ID: 34376770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
    Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
    PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies.
    Singh P; Guin D; Pattnaik B; Kukreti R
    Gene; 2024 Feb; 895():147993. PubMed ID: 37977320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
    Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
    Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
    Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.
    Moll M; Peljto AL; Kim JS; Xu H; Debban CL; Chen X; Menon A; Putman RK; Ghosh AJ; Saferali A; Nishino M; Hatabu H; Hobbs BD; Hecker J; McDermott G; Sparks JA; Wain LV; Allen RJ; Tobin MD; Raby BA; Chun S; Silverman EK; Zamora AC; Ortega VE; Garcia CK; Barr RG; Bleecker ER; Meyers DA; Kaner RJ; Rich SS; Manichaikul A; Rotter JI; Dupuis J; O'Connor GT; Fingerlin TE; Hunninghake GM; Schwartz DA; Cho MH
    Am J Respir Crit Care Med; 2023 Oct; 208(7):791-801. PubMed ID: 37523715
    [No Abstract]   [Full Text] [Related]  

  • 39. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants Supports Functional Roles of
    Borie R; Cardwell J; Konigsberg IR; Moore CM; Zhang W; Sasse SK; Gally F; Dobrinskikh E; Walts A; Powers J; Brancato J; Rojas M; Wolters PJ; Brown KK; Blackwell TS; Nakanishi T; Richards JB; Gerber AN; Fingerlin TE; Sachs N; Pulit SL; Zappala Z; Schwartz DA; Yang IV
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1259-1270. PubMed ID: 35816432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.